<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>An elevated level of <z:chebi fb="0" ids="17230">Homocysteine</z:chebi> (<z:chebi fb="0" ids="17230">Hcy</z:chebi>) is a risk factor for vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Cysthathionine beta Synthase (CBS) gene is involved in the clearance of <z:chebi fb="0" ids="17230">Hcy</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Homozygous individuals for (CBS-/-) die early, but heterozygous for (CBS-/+) survive with high levels of <z:chebi fb="0" ids="17230">Hcy</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>The gamma-Amino <z:chebi fb="4" ids="30772">Butyric Acid</z:chebi> (<z:chebi fb="3" ids="16865">GABA</z:chebi>) presents in the central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) and functions as an inhibitory neurotransmitter </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="0" ids="17230">Hcy</z:chebi> competes with <z:chebi fb="3" ids="16865">GABA</z:chebi> at the <z:chebi fb="3" ids="16865">GABA</z:chebi>(A) receptor and affects the <z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi> function </plain></SENT>
<SENT sid="5" pm="."><plain>We hypothesize that <z:chebi fb="0" ids="17230">Hcy</z:chebi> causes a decrease in blood flow to the brain due to increase in vascular resistance (VR) because of arterial remodeling in the carotid artery (CA) </plain></SENT>
<SENT sid="6" pm="."><plain>Blood pressure and blood flow in CA of <z:mp ids='MP_0002169'>wild type</z:mp> (WT), CBS-/+, CBS-/+ <z:chebi fb="3" ids="16865">GABA</z:chebi>(A)-/- double knockout, and <z:chebi fb="3" ids="16865">GABA</z:chebi>(A)-/- were measured </plain></SENT>
<SENT sid="7" pm="."><plain>CA was stained with trichrome, and the brain permeability was measured </plain></SENT>
<SENT sid="8" pm="."><plain>Matrix Metalloproteinases (MMP-2 and MMP-9), tissue inhibitor of metalloproteinase (TIMP-3, TIMP-4), elastin, and collagen-III expression were measured by real-time polymerase chain reaction (RT-PCR) </plain></SENT>
<SENT sid="9" pm="."><plain>Results showed an increase in VR in CBS-/+/<z:chebi fb="3" ids="16865">GABA</z:chebi>(A)-/-double knockout&gt;CBS-/+/&gt;<z:chebi fb="3" ids="16865">GABA</z:chebi>(A)-/- compared to WT mice </plain></SENT>
<SENT sid="10" pm="."><plain>Increased MMP-2, MMP-9, collagen-III and TIMP-3 mRNA levels were found in <z:chebi fb="3" ids="16865">GABA</z:chebi>(A)-/-, CBS-/+, CBS-/+/<z:chebi fb="3" ids="16865">GABA</z:chebi>(A) double knockout compared to WT </plain></SENT>
<SENT sid="11" pm="."><plain>The levels of TIMP-4 and elastin were decreased, whereas the levels of MMP-2, MMP-9 and TIMP-3 increased, which indirectly reflected the arterial resistance </plain></SENT>
<SENT sid="12" pm="."><plain>These results suggested that <z:chebi fb="0" ids="17230">Hcy</z:chebi> caused arterial remodeling in part, by increase in collagen/elastin ratio thereby increasing VR leading to the decrease in CA blood flow </plain></SENT>
</text></document>